Not Yet RecruitingNot Applicable

Home and Clinic Rehabilitation in Subacute Stroke

72 participantsStarted 2026-06

Plain-language summary

The goal of this clinical trial is to learn if adding scheduled home-based rehabilitation to clinic-based rehabilitation improves walking ability and daily activities in people aged 40 to 50 with sub-acute stroke. The main questions it aims to answer are: * Does adding home exercises improve walking ability in people with sub-acute stroke? * Does adding home exercises improve the ability to do daily activities in people with sub-acute stroke? Researchers will compare clinic-based rehabilitation plus home-based rehabilitation to clinic-based rehabilitation alone to see if adding home exercises leads to better recovery after stroke. Participants will: * Attend physical therapy at the hospital 3 days per week for 12 weeks * Do walking practice, balance training, and leg exercises at the clinic * Do home exercises including marching, step-ups, sit-to-stand, and balance exercises on non-clinic days (home exercise group only) * Track home exercises using a weekly logbook * Be tested at the start and after 12 weeks

Who can participate

Age range

40 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Age 40-50 years old Male and female Patients having stroke 3 months to 6 months prior to enrollment Able to comprehend and adhere to instructions Grade 1+ spasticity on Modified Ashworth Scale Modified Rankin Scale score of 3-4 with ability to maintain sitting balance for at least 1 hour Exclusion Criteria: Myocardial infarction Other neurological deficits leading to disability Contractures Severe dysphasia and cognitive impairment Need for further surgery or medical care

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Timed Up and Go Test (TUG)

Timeframe: Baseline and 12 weeks

Lawton-Brody Instrumental Activities of Daily Living Scale (IADL)

Timeframe: Baseline and 12 weeks

Trial details

NCT IDNCT07613554

SponsorUniversity of Lahore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01

View on ClinicalTrials.gov More Sub-acute Stroke trials